Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
US12024568B2 · kind B2 · utility
1Cited by
10References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 13, 2013 |
| Grant date | Jul 2, 2024 |
| Priority date | — |
| Expiry date | Sep 13, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods to inhibit or treat brain cancers by locally inhibiting expression or activity of growth factors or growth factor receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.